Clinical Trials
- Alzheimer's
A Randomized, Double-Blind, Placebo controlled, Parallel-group, Multicenter Study to Assess the Efficacy and Safety of JNJ-63733657, an anti-tau Monoclonal Antibody, in Participants with Early Alzheimer's Disease
- Ages55 years - 80 years
- GenderBoth
- Alzheimer's
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
- Ages60 years - 85 years
- GenderBoth
- Alzheimer's
A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)
- Ages50 years - 80 years
- GenderBoth
- Aging, Mental Health & Behavioral Research
A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy
- Ages50 years - 85 years
- GenderBoth
- Alzheimer's
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
- Ages55 years - 80 years
- GenderBoth
- Mental Health & Behavioral Research
Imaging mGluR5 and synaptic density in psychiatric disorders
- Ages18 years - 80 years
- GenderBoth
- Brain, Spinal Cord & Nervous System, Alzheimer's
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
- Ages50 years - 90 years
- GenderBoth
- Mental Health & Behavioral Research
Studying the Adult Brain